{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T18:41:07Z","timestamp":1793817667354,"version":"4.6.1"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.humpath.2025.106013","type":"journal-article","created":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T00:21:29Z","timestamp":1765498889000},"page":"106013","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Gastric neuroendocrine tumors associated with acid suppressant drugs are frequently associated with very prolonged drug use and may show unconventional morphologies"],"prefix":"10.1016","volume":"168","author":[{"given":"Mahzad","family":"Azimpouran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin M.","family":"Waters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew E.","family":"Hendifar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Gangi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Kozak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maha","family":"Guindi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith K.","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brent K.","family":"Larson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3188-0525","authenticated-orcid":false,"given":"Danielle A.","family":"Hutchings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2025.106013_bib1","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1002\/cncr.11105","article-title":"A 5-decade analysis of 13,715 carcinoid tumors","volume":"97","author":"Modlin","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2025.106013_bib2","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1055\/s-0030-1255564","article-title":"Neuroendocrine tumors of the stomach (gastric carcinoids) are on the rise: small tumors, small problems?","volume":"42","author":"Scher\u00fcbl","year":"2010","journal-title":"Endoscopy"},{"key":"10.1016\/j.humpath.2025.106013_bib3","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s00428-007-0452-1","article-title":"TNM staging of midgut and hindgut (neuro) endocrine tumors: a consensus proposal including a grading system","volume":"451","author":"Rindi","year":"2007","journal-title":"Virchows Arch"},{"key":"10.1016\/j.humpath.2025.106013_bib4","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1634\/theoncologist.2008-0207","article-title":"Carcinoid tumors","volume":"13","author":"Pinchot","year":"2008","journal-title":"Oncologist"},{"key":"10.1016\/j.humpath.2025.106013_bib5","article-title":"Digestive System tumours","volume":"vol. 1","year":"2019"},{"key":"10.1016\/j.humpath.2025.106013_bib6","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1159\/000098007","article-title":"Well-differentiated gastric tumors\/carcinomas","volume":"84","author":"Ruszniewski","year":"2006","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.humpath.2025.106013_bib7","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1111\/his.14226","article-title":"New insights into the classification of gastric neuroendocrine tumours, expanding the spectrum of ECL-cell tumours related to hypergastrinaemia","volume":"77","author":"La Rosa","year":"2020","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2025.106013_bib8","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.gtc.2013.01.009","article-title":"Gastric carcinoids (neuroendocrine neoplasms)","volume":"42","author":"Kidd","year":"2013","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1016\/j.humpath.2025.106013_bib9","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1159\/000443168","article-title":"ENETS consensus guidelines update for gastroduodenal neuroendocrine neoplasms","volume":"103","author":"Delle Fave","year":"2016","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.humpath.2025.106013_bib10","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1093\/ajcp\/aqad021","article-title":"Clinicopathologic features of non-type 1\/2 gastric neuroendocrine tumors and their associated mucosal changes","volume":"160","author":"Logan","year":"2023","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.humpath.2025.106013_bib11","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.bpg.2005.05.002","article-title":"Endocrine tumours of the stomach","volume":"19","author":"Delle Fave","year":"2005","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.humpath.2025.106013_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2023.100098","article-title":"The morphologic spectrum of gastric type 1 enterochromaffin-like cell neuroendocrine tumors","volume":"36","author":"Poveda","year":"2023","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2025.106013_bib13","doi-asserted-by":"crossref","first-page":"2914","DOI":"10.1093\/hmg\/ddv054","article-title":"Exome sequencing identifies ATP4A gene as responsible of an atypical familial type I gastric neuroendocrine tumour","volume":"24","author":"Calvete","year":"2015","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.humpath.2025.106013_bib14","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s12022-021-09662-5","article-title":"Molecular pathology of well-differentiated Gastro-entero-pancreatic neuroendocrine tumors","volume":"32","author":"Asa","year":"2021","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.humpath.2025.106013_bib15","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1111\/his.14220","article-title":"Gastric neuroendocrine tumours from long-term proton pump inhibitor users are indolent tumours with good prognosis","volume":"77","author":"Trinh","year":"2020","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2025.106013_bib16","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1159\/000445165","article-title":"The clinicopathologic heterogeneity of grade 3 gastroenteropancreatic neuroendocrine neoplasms: morphological differentiation and proliferation identify different prognostic categories","volume":"104","author":"Milione","year":"2017","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.humpath.2025.106013_bib17","doi-asserted-by":"crossref","first-page":"366","DOI":"10.5858\/arpa.2020-0315-OA","article-title":"Enterochromaffin-like cell hyperplasia-associated gastric neuroendocrine tumors may arise in the setting of proton pump inhibitor use","volume":"146","author":"Rais","year":"2022","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.humpath.2025.106013_bib18","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1111\/apt.12012","article-title":"Gastric carcinoids after long-term use of a proton pump inhibitor","volume":"36","author":"Jianu","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.humpath.2025.106013_bib19","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21020662","article-title":"Proton pump inhibitor use, hypergastrinemia, and gastric carcinoids-what is the relationship?","volume":"21","author":"McCarthy","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.humpath.2025.106013_bib20","doi-asserted-by":"crossref","DOI":"10.1177\/17562848211051463","article-title":"Association between proton-pump inhibitors and the risk of gastric cancer: a systematic review with meta-analysis","volume":"14","author":"Segna","year":"2021","journal-title":"Therap Adv Gastroenterol"},{"key":"10.1016\/j.humpath.2025.106013_bib21","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1007\/s10620-015-4014-0","article-title":"Solitary gastric carcinoid tumor associated with long-term use of omeprazole: a case report and review of the literature","volume":"61","author":"Nandy","year":"2016","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.humpath.2025.106013_bib22","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1023\/A:1018881617038","article-title":"Human gastric carcinoid detected during long-term antiulcer therapy of H2 receptor antagonist and proton pump inhibitor","volume":"43","author":"Haga","year":"1998","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.humpath.2025.106013_bib23","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1007\/BF02093608","article-title":"Omeprazole produces parietal cell hypertrophy and hyperplasia in humans","volume":"41","author":"Driman","year":"1996","journal-title":"Dig Dis Sci"},{"issue":"Suppl 1","key":"10.1016\/j.humpath.2025.106013_bib24","first-page":"S1","article-title":"Hyperplastic, dysplastic, and neoplastic enterochromaffin-like-cell proliferations of the gastric mucosa. Classification and histogenesis","volume":"19","author":"Solcia","year":"1995","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2025.106013_bib25","doi-asserted-by":"crossref","first-page":"506","DOI":"10.3109\/00365521.2013.878381","article-title":"Gastric carcinoid in the absence of atrophic body gastritis and with low Ki67 index: a clinical challenge","volume":"49","author":"Lahner","year":"2014","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.humpath.2025.106013_bib26a","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3109\/00365521.2011.627444","article-title":"Gastric neuroendocrine carcinoma after long-term use of proton pump inhibitor","volume":"47","author":"Jianu","year":"2012","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.humpath.2025.106013_bib26b","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.3109\/00365521.2015.1054426","article-title":"Gastric neuroendocrine neoplasms and proton pump inhibitors: fact or coincidence?","volume":"50","author":"Cavalcoli","year":"2015","journal-title":"Scand J Gastroenterol"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817725003004?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817725003004?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T01:46:50Z","timestamp":1770083210000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817725003004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":27,"alternative-id":["S0046817725003004"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2025.106013","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gastric neuroendocrine tumors associated with acid suppressant drugs are frequently associated with very prolonged drug use and may show unconventional morphologies","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2025.106013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106013"}}